RE-BVS – Piemonte Repository

Sfoglia per AUTORE
RENI M
Collezione AOU Città della Salute di Torino

Items : 6

A pilot study of chlorambucil in pre-treated metastatic pancreatic adenocarcinoma patients bearing germline BRCA or other DNA damage repair system variants. in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] / Pancreatology. 2024 Nov;24(7):1066-1072. doi: 10.1016/j.pan.2024.09.006. Epub 2024 Sep 12.

2024
AOU Città della Salute di Torino

Carconi C; Bosi C; Scartozzi M; Cergnul M; Cinausero M; Faloppi L; Garajova I; Lonardi S; Pecora I; Pisanu L; Spadi R; Spallanzani A; Peretti U; Macchini M; Orsi G; Reni M;

Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR. in PloS one / PLoS One. 2018 Jan 19;13(1):e0191593. doi: 10.1371/journal.pone.0191593. eCollection 2018.

2018
AOU Città della Salute di Torino

Spadi R; Avallone A; Reni M; Aprile G; Satolli MA; Nasti G; Cereda S; Gammaitoni L; Cagnazzo C; Fenocchio E; Cavalloni G; Peraldo-Neia C; Venesio T; Martin V; Doglioni C; Frattini M; Aglietta M; Leone F;

Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2017 Nov;4(11):e510-e523. doi: 10.1016/S2352-3026(17)30174-6. Epub 2017 Oct 17.

2017
AOU Città della Salute di Torino

Ferreri AJM; Cwynarski K; Pulczynski E; Fox CP; Schorb E; La Rosée P; Binder M; Fabbri A; Torri V; Minacapelli E; Falautano M; Ilariucci F; Ambrosetti A; Roth A; Hemmaway C; Johnson P; Linton KM; Pukrop T; Sønderskov Gørløv J; Balzarotti M; Hess G; Keller U; Stilgenbauer S; Panse J; Tucci A; Orsucci L; Pisani F; Levis A; Krause SW; et alii...

Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2016 May;3(5):e217-27. doi: 10.1016/S2352-3026(16)00036-3. Epub 2016 Apr 6.

2016
AOU Città della Salute di Torino

Ferreri AJ; Cwynarski K; Pulczynski E; Ponzoni M; Deckert M; Politi LS; Torri V; Fox CP; Rosée PL; Schorb E; Ambrosetti A; Roth A; Hemmaway C; Ferrari A; Linton KM; Rudà R; Binder M; Pukrop T; Balzarotti M; Fabbri A; Johnson P; Gørløv JS; Hess G; Panse J; Pisani F; Tucci A; Stilgenbauer S; Hertenstein B; Keller U; et alii...

Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2016 Jan;77(1):109-14. doi: 10.1007/s00280-015-2919-0. Epub 2015 Dec 10.

2016
AOU Città della Salute di Torino

Palazzo V; Lutrino SE; Marino D; Martines C; Vaccaro V; Novarino A; Auriemma A; Belli C; Santini D; Vasile E; Mosconi S; Galiano A; Aprile G; Leone F; Cordio S; Milella M; Cereda S; Reinach B; Aldrighetti L; Reni M;

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study). in Cancer / Cancer. 2016 Feb 15;122(4):574-81. doi: 10.1002/cncr.29778. Epub 2015 Nov 5.

2016
AOU Città della Salute di Torino

Siena S; Ciuffreda L; Fasola G; Aprile G; Cagnazzo C; Amatu A; Montano M; Nasti G; Spadi R; Belli C; Filippi R; Cereda S; Marino D; Leone F; Reni M; Aglietta M;